Rapid genetic test for IVF identifies FSHR variant in 60 minutes, guiding IVF hormone selection and improving in vitro fertilization success.
The complexity of software architecture and diverse user interactions presents challenges to conventional testing approaches. Traditional test automation and quality assurance engineering represented ...
Foundation Medicine, Inc., a global precision medicine company, today announced the launch of its Whole Genome Sequencing (WGS) Germline test for research use. This important portfolio expansion is ...
Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded ...
Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions A patient’s tumor profile has the potential ...
CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that the validation study of ...
Acrivon (ACRV) develops precision cancer medicines and then uses its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics, or AP3, to match ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% ...
Acquired CARD11 Mutation Promotes BCR Independence in Diffuse Large B Cell Lymphoma Despite the well-understood benefits of biomarker and genetic testing in precision medicine, uptake remains low, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results